Contract HHSO100201700012C

Merck Sharp & Dohme Llc · Department Of Health And Human Services · June 27, 2024

Cost Plus Fixed FeeFull & Open CompetitionNAICS 541711

Merck Sharp & Dohme Llc was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on June 27, 2024 for $236.31 million (current value) of work in research and development in biotechnology. Performance is in Whitehouse Station, NJ. It was awarded under full and open competition. It uses cost-plus contract pricing. If all options are exercised, the contract could reach $291.37 million.

Current value
$236.31M
Potential value
$291.37M
if all options exercised
Modifications
0
Base award only

Contract details

PIID
HHSO100201700012C
Award type
Definitive Contract
Pricing
Cost Plus Fixed Fee
Set-aside
No Set Aside Used.
Competition
Full And Open Competition
NAICS
541711 · Research And Development In Biotechnology
Product / service
Drugs And Biologicals
Place of performance
Whitehouse Station, NJ
First action
June 27, 2024

Description

MERCK - EBOLA ZAIRE VACCINE EXERCISE AND FUND OPTION 6 IN ORDER TO CONTINUE TO MEET THE REQUIREMENT OF MAINTAINING 1.13 MILLION DOSES OF ERVEBO.

Modification timeline

  • June 27, 2024
    Mod P00009 · Change Order
    $236.31M

Similar contracts

RecipientAgencyDateObligated
University Of IllinoisDepartment Of Health And Human ServicesMarch 26, 2026$2.27M
Battelle Memorial InstituteDepartment Of Health And Human ServicesMarch 25, 2026$9.65M
University Of Texas Medical Branch At GalvestonDepartment Of Health And Human ServicesMarch 23, 2026$1.61M
Regeneron Pharmaceuticals IncDepartment Of Health And Human ServicesMarch 19, 2026$8.60M
Battelle Memorial InstituteDepartment Of Health And Human ServicesMarch 17, 2026$2.22M
Battelle Memorial InstituteDepartment Of Health And Human ServicesMarch 17, 2026$2.23M

Top contractors in NAICS 541711

Lifetime obligated dollars across all federal contracts in this NAICS code.

#ContractorContractsObligated
1Alliance For Energy Innovation, Llc1$338.10M
2Battelle National Biodefense Institute, Llc2$24.13M
3Battelle Memorial Institute7$2.21M
4Bradshaw Engineering And Technical Services Llc1$0
5Uk Health Security Agency1$0
6Medicines Company, The1$0
7University Of North Carolina At Chapel Hill1$0
8Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center1$0
9Dnae Group Holdings Limited1$0
10University Of Texas Medical Branch At Galveston2$0

Track this on BesaGov

Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.

✓ You’re on the list. We’ll never spam you.

Helpful guides

Continue learning

See all guides →
More on BesaGov

Keep researching

Track this contract, set alerts on similar opportunities, and build proposal pipelines on BesaGov.
Sign up free

Frequently asked questions

What is contract HHSO100201700012C?

Contract HHSO100201700012C is a federal contract awarded to Merck Sharp & Dohme Llc by Department Of Health And Human Services on June 27, 2024 for $236.31 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY. It has been modified 0 times since the base award.

Who won contract HHSO100201700012C?

Merck Sharp & Dohme Llc won contract HHSO100201700012C from Department Of Health And Human Services.

How much is contract HHSO100201700012C worth?

Contract HHSO100201700012C has obligated $0 to date but carries a potential ceiling of $291.37 million if fully funded and all options are exercised.